| Income Statement |
| Total Revenue | 59.79M |
|
| Revenues (USD) | 43.33M |
| Cost of Revenue | 43.39M |
| Gross Profit | 16.41M |
| Operating Expenses | 36.36M |
| Research and Development Expense | 2.03M |
| Selling, General and Administrative Expense | 23.61M |
| Operating Income | -19.95M |
| Net Income | -921.00K |
| Net Income Common Stock | -921.00K |
| Net Income Common Stock (USD) | -667.39K |
| Consolidated Income | -921.00K |
| Earnings per Basic Share | -0.01 |
| Earnings per Basic Share (USD) | 0.00 |
| Earnings per Diluted Share | -0.01 |
| Earning Before Interest & Taxes (EBIT) | -921.00K |
| Earning Before Interest & Taxes (USD) | -667.39K |
| Weighted Average Shares | 135.13M |
| Balance Sheet |
| Cash and Equivalents | 53.94M |
| Cash and Equivalents (USD) | 39.09M |
| Investments | 57.94M |
| Investments Current | 811.00K |
| Investments Non-Current | 57.13M |
| Trade and Non-Trade Receivables | 53.39M |
| Current Assets | 250.09M |
| Property, Plant & Equipment Net | 120.84M |
| Total Assets | 521.31M |
| Current Liabilities | 88.75M |
| Total Liabilities | 149.50M |
| Accumulated Retained Earnings (Deficit) | -589.68M |
| Accumulated Other Comprehensive Income | 481.00K |
| Shareholders Equity | 371.81M |
| Shareholders Equity (USD) | 269.43M |
| Assets Non-Current | 271.23M |
| Goodwill and Intangible Assets | 91.74M |
| Inventory | 117.93M |
| Liabilities Non-Current | 60.76M |
| Trade and Non-Trade Payables | 73.14M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.03M |
| Net Cash Flow from Financing | -451.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.22M |
| Capital Expenditure | -223.00K |
| Issuance (Repayment) of Debt Securities | -400.00K |
| Net Cash Flow from Investing | -1.41M |
| Net Cash Flow - Investment Acquisitions and Disposals | -1.62M |
| Net Cash Flow from Operations | -6.76M |
| Effect of Exchange Rate Changes on Cash | 404.00K |
| Share Based Compensation | 728.00K |